Unfortunately the very existence of this presentation suggests Kilian and the board are thinking about raising funds again.
Lining up trial outcomes (real ones - not sites opened) against cash spend seems to be the sound thing to do analytically.
Looking at Kilian's history (past) of delivery against his chances of future performance seems prudent analytically too.
What has Kilian done since replacing Ross?
Ann: Investor Presentation, page-11
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
-0.010(3.70%) |
Mkt cap ! $46.97M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.5¢ | 25.5¢ | $23.84K | 92.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10800 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 24939 | 1 |
View Market Depth
| Last trade - 14.33pm 09/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |